About Devonian
Devonian is a company based in Quebec City (Canada) founded in 2013.. The company has 8 employees as of July 31, 2024. Devonian has completed 1 acquisition, including Altius Healthcare. Devonian offers products and services including Therapeutics and Cosmeceuticals. Devonian operates in a competitive market with competitors including LEO Pharma, Incyte, Nimbus Therapeutics, Escient Pharmaceuticals and Aclaris Therapeutics, among others.
- Headquarter Quebec City, Canada
- Employees 8 as on 31 Jul, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Groupe Santé Devonian Inc.
-
Annual Revenue
$12.39 M (USD)659.6as on Jul 31, 2024
-
Net Profit
$-847.93 K (USD)73.38as on Jul 31, 2024
-
EBITDA
$-129 K (USD)95.24as on Jul 31, 2024
-
Latest Funding Round
$1.65 M (USD), Post-IPO
Aug 08, 2025
-
Investors
-
Employee Count
8
as on Jul 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Devonian
Devonian is a publicly listed company on the TSXV with ticker symbol GSD in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Devonian
Devonian offers a comprehensive portfolio of products and services, including Therapeutics and Cosmeceuticals. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops drugs for inflammatory autoimmune diseases treatment
Products for dermatological and health applications
Unlock access to complete
Unlock access to complete
Funding Insights of Devonian
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $1.7M
-
First Round
First Round
(06 Aug 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Post-IPO - Devonian | Valuation |
investors |
|
| Mar, 2024 | Amount | Post-IPO - Devonian | Valuation |
investors |
|
| May, 2023 | Amount | Post-IPO - Devonian | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Devonian
Devonian has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Altius Healthcare. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Nursing, assisted living, and home care services are provided.
|
1990 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Devonian
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Devonian Comparisons
Competitors of Devonian
Devonian operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LEO Pharma, Incyte, Nimbus Therapeutics, Escient Pharmaceuticals and Aclaris Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of drugs for treating dermatology diseases
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Devonian
Frequently Asked Questions about Devonian
When was Devonian founded?
Devonian was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Where is Devonian located?
Devonian is headquartered in Quebec City, Canada. It is registered at Quebec City, Quebec, Canada.
Who is the current CEO of Devonian?
Andre P Boulet is the current CEO of Devonian.
How many employees does Devonian have?
As of Jul 31, 2024, the latest employee count at Devonian is 8.
What is the annual revenue of Devonian?
Annual revenue of Devonian is $12.39M as on Jul 31, 2024.
What does Devonian do?
Developer of drugs for inflammatory diseases and dermatology. The flagship product, Thykamine, has shown anti-inflammatory and anti-oxidant properties, as per company claims, and is currently under development for the treatment of ulcerative colitis, atopic dermatitis, eczema, and psoriasis. The company also develops cosmetic products which include anti-aging products, and sun care products for women and men.
Who are the top competitors of Devonian?
Devonian's top competitors include Escient Pharmaceuticals, Nimbus Therapeutics and LEO Pharma.
What products or services does Devonian offer?
Devonian offers Therapeutics and Cosmeceuticals.
Is Devonian publicly traded?
Yes, Devonian is publicly traded on TSXV under the ticker symbol GSD.
How many acquisitions has Devonian made?
Devonian has made 1 acquisition, including Altius Healthcare.
What is Devonian's ticker symbol?
The ticker symbol of Devonian is GSD on TSXV.